Matthew Moore
Chief Operating Officer at VENTYX BIOSCIENCES, INC.
Net worth: 1 M $ as of 29/04/2024
Profile
Matthew Moore is currently the Chief Business Officer & Senior Vice President at Arcutis Biotherapeutics, Inc. He previously worked as the Vice President-Corporate Business Development at Allergan Ltd.
(Ireland).
He completed his undergraduate degree at Trinity College.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
01/05/2024 | 145,505 ( 0.13% ) | 1 M $ | 29/04/2024 |
Matthew Moore active positions
Companies | Position | Start |
---|---|---|
VENTYX BIOSCIENCES, INC. | Chief Operating Officer | 15/05/2024 |
Former positions of Matthew Moore
Companies | Position | End |
---|---|---|
ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 30/04/2024 |
ALLERGAN PLC | Corporate Officer/Principal | 31/12/2019 |
Training of Matthew Moore
Trinity College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
VENTYX BIOSCIENCES, INC. | Health Technology |
Private companies | 1 |
---|---|
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Matthew Moore